Ra. Howlett et al., Skeletal muscle metabolism during high-intensity sprint exercise is unaffected by dichloroacetate or acetate infusion, J APP PHYSL, 87(5), 1999, pp. 1747-1751
This study investigated whether increased provision of oxidative substrate
would reduce the reliance on nonoxidative ATP production and/or increase po
wer output during maximal sprint exercise. The provision of oxidative subst
rate was increased at the onset of exercise by the infusion of acetate (AC;
increased resting acetylcarnitine) or dichloroacetate [DCA; increased acet
ylcarnitine and greater activation of pyruvate dehydrogeanse (PDH-a)]. Subj
ects performed 10 s of maximal cycling on an isokinetic ergometer on three
occasions after either DCA, AC, or saline (Con) infusion. Resting PDH-a wit
h DCA was increased significantly over AC and Con trials (3.58 +/- 0.4 vs.
0.52 +/- 0.1 and 0.74 +/-: 0.1 mmol(.)kg wet muscle(-1.) min(-1)), DCA and
AC significantly increased resting acetyl-CoA(35.2 +/- 4.4 and 22.7 +/- 2.9
vs. 10.2 +/- 1.3 mu mol/kg dry muscle) and acetylcarnitine (12.9 +/- 1.4 a
nd 11.0 +/- 1.0 vs. 3.3 +/- 0.6 mmol/kg dry muscle) over Con. Resting conte
nts of phosphocreatine, lactate, ATP, and glycolytic intermediates were not
different among trials. Average power output and total work done were not
different among the three 10-s sprint trials. Postexercise, PDH-a in AC and
Con trials had increased significantly but was still significantly lower t
han in DCA trial. Acetyl-CoA did not increase in any trial, whereas acetylc
arnitine increased significantly only in DCA. Exercise caused identical dec
reases inATP and phosphocreatine and identical increases in lactate, pyruva
te, and glycolytic intermediates in all trials. These data suggest that the
re is an inability to utilize extra oxidative substrate (from either stored
acetylcarnitine or increased PDH-a) during exercise at this intensity, pos
sibly because of O-2 and/or metabolic limitations.